Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
individual with a PhD in molecular biology, developmental biology, or a related field. Experience in rodent work and immunohistochemistry preferred. This position is for one year and is renewable contingent
-
scientists with PhD and/or MD in an appropriate field. Experience in molecular biology, biochemistry, molecular genetics, mouse behavioral assays as well as willingness to learn associated areas are positives
-
Center at University of Maryland School of Medicine. The candidate will study lung cancer biology and how genotype/phenotype plays a role in therapeutic response to existing chemotherapies as well as novel
-
expertise in high throughput technologies, basic molecular and cellular biology techniques, mammalian cell culture, CRISPR-Cas9 (for gene knockout and DNA methylation), lentivirus generation, flow cytometry
-
POSTDOC position in Cardiovascular Biology - (2400009W) The Department of Medicine at the University of Maryland School of Medicine is recruiting a Postdoctoral fellow. Preference to candidates with
-
Structural Biology, and Population Science. The co-leader should ideally be an NIH funded investigator, at the associate professor level or above. The co-leader will be a member of UMGCCC senior leadership
-
hypertension. Multidisciplinary approaches include molecular and cellular biology, physiological evaluation, quantitative histology, as well as bulk or single-cell omics. Qualifications PhD or MD in Molecular
-
programs within UMGCCC including, Experimental Therapeutics, Tumor Immunology & Immunotherapy, Molecular and Structural Biology, and Hormone Related Cancers. The co-leader should ideally be an NIH funded
-
), professional organizations, and other endeavors is expected. Qualifications QUALIFICATIONS PhD in Bioengineering, Molecular Biology, Pharmaceutical Sciences, Toxicology, or a related field. A minimum of three (3
-
in multi-parameter flow cytometry, tissue culture, and working with mice. The position will require a strong background in influenza vaccine development, Toll-like receptor 4 (TLR4) biology, and